By Scientia Professor Vlado Perkovic

Conference Papers

de Galan BE; Chalmers J; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Macmahon S; Neal B; Mogensen C-E; Marre M; Harrap SB; Poulter NR; Cooper ME; Mancia G, 2008, 'Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Berlin, pp. S189 - S189, presented at 18th Scientific Meeting of the European-Society-of-Hypertension/22nd Scientific Meeting of the International-Society-of-Hypertension, GERMANY, Berlin, 14 June 2008 - 19 June 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257197001234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Huxley R; Ninomiya T; Verdon C; Barzi F; Perkovic V, 2008, 'Proteinuria is associated with a 50% increased risk of coronary heart disease: a meta-analysis of prospective cohort studies', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 593 - 593

Cooper B; Gallery E; Mclennan J; Ross-Styles M; Waugh D; Mcginn C; Pollock C; Perkovic V; Gyory A, 2008, 'THE RENAL CHARACTERISTICS OF PATIENTS WITH A HISTORY OF LITHIUM EXPOSURE AS DETERMINED BY FORMAL RENAL FUNCTION TESTING', in NEPHROLOGY, WILEY-BLACKWELL, pp. A145 - A145

Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Neal B; MacMahon S; Chalmers J, 2007, 'LOWER BLOOD PRESSURE AND THE RISK OF STROKE IN CHRONIC KIDNEY DISEASE: RESULTS OF THE PROGRESS TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Adelaide, pp. 173 - 173, presented at 29th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Adelaide, 05 December 2007 - 08 December 2007

Gallagher M; Jardine M; Cass A; Perkovic V; Petrie J; Mcdonald S; Eris J, 2007, '20 YEAR OUTCOMES OF THE AUSTRALIAN MULTICENTRE RANDOMISED TRIAL OF CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. A19 - A19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Neal B; Macmahon S; Chalmers J, 2007, 'THE EFFICACY OF LOWER BLOOD PRESSURE GOALS ON THE PREVENTION OF STROKE IN CHRONIC KIDNEY DISEASE: DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gallagher M; Jardine M; Cass A; McDonald S; Perkovic V; Petrie J; Eris J, 2007, '20 year outcomes of the Australian multicentre randomised trial of cyclosporine withdrawal in renal transplantation.', in AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL PUBLISHING, CA, San Francisco, pp. 206 - 207, presented at Annual American Transplant Congress, CA, San Francisco, 05 May 2007 - 09 May 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246370200232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verdon C; Perkovic V; Ninomiya T; Barzi F; Craig J; Cass A; Huxley R, 2007, 'PROTEINURIA AS A PREDICTOR OF CORONARY HEART DISEASE - A SYSTEMATIC REVIEW', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31

Ninomiya T; Perkovic V; Verdon C; Barzi F; Craig J; Cass A; Huxley R, 2007, 'PROTEINURIA AS A PREDICTOR OF STROKE - A SYSTEMATIC REVIEW', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31

Howard K; Salkeld G; White S; Chadban S; Craig J; Cass A; Mcdonald S; Perkovic V, 2006, 'COST EFFECTIVENESS OF SCREENING FOR THE EARLY DIAGNOSIS AND TREATMENT OF RISK FACTORS FOR CHRONIC KIDNEY DISEASE: A MARKOV MONTE CARLO MICROSIMULATION USING MARCK-E (MODEL FOR THE ASSESSMENT OF RISK FACTORS FOR CHRONIC KIDNEY DISEASE - ECONOMICS)', in NEPHROLOGY, WILEY-BLACKWELL, pp. A9 - A9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

White S; Mcgeechan K; Jones M; Cass A; Chadban S; Perkovic V; Roderick P, 2006, 'THE RELATIONSHIP BETWEEN CHRONIC KIDNEY DISEASE AND INDIVIDUAL-LEVEL SOCIOECONOMIC FACTORS: THE THREE COUNTRY KIDNEY DISEASE STUDY (3CKD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. A13 - A14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lian M; Nicholls K; Perkovic V; Becker G, 2006, 'THE ROLE OF NOCTURNAL HAEMODIALYSIS AND ARTERIAL STIFFNESS', in NEPHROLOGY, WILEY-BLACKWELL, pp. A30 - A30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Algert C; Arima H; Ninomiya T; Gallagher M; Cass A; Neal B; Chalmers J; MacMahon S, 2006, 'Reductions in the risks of vascular events and stroke in patients with and without chronic kidney disease; New data from the PROGRESS trial', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, pp. 1475 - 1475, presented at Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA

Perkovic V; Algert C; Arima H; Gallagher M; Cass A; Neal B; Macmahon S; Chalmers J, 2006, 'REDUCTIONS IN THE RISKS OF VASCULAR EVENTS AND STROKE IN PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE; NEW DATA FROM THE PROGRESS TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A21 - A21

Perkovic V; Algert C; Arima H; Gallagher M; Cass A; Neal B; Macmahon S; Chalmers J, 2006, 'THE PREDICTIVE ABILITY OF DIFFERENT MEASURES OF KIDNEY FUNCTION: NEW DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A46 - A46

Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'Dialysis adequacy (HD) guidelines: Dose of haemodialysis', in Nephrology, pp. S61 - S63, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_1.x

Masterson R; Leikis M; Perkovic V; Nicholls K; Walker R, 2003, 'Sirolimus: A single center experience in combination with calcineurin inhibitors', in Transplantation Proceedings, pp. S99 - S104, http://dx.doi.org/10.1016/S0041-1345(03)00219-7

Conference Posters

Barratt J; Rovin B; Zhang H; Kashihara N; Maes B; Rizk D; Trimarchi H; Sprangers B; Meier M; Kollins D; Wang W; Magirr A; Perkovic V, 2022, 'POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS', Vol. 7, pp. s236, http://dx.doi.org/10.1016/j.ekir.2022.01.577

LI J; NEAL B; HEERSPINK HL; ARNOTT C; CANNON C; AGARWAL R; BAKRIS G; CHARYTAN DM; ZEEUW DD; GREENE TOM; LEVIN A; OH R; POLLOCK CA; WHEELER DC; YAVIN Y; ZHANG H; ZINMAN B; DI TANNA GL; PERKOVIC V; MAHAFFEY KW; JARDINE MEG, 2020, '1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-1130-p

FERRANNINI E; BALDI S; SCOZZARO T; TESFAYE F; SHAW W; ROSENTHAL N; MAHAFFEY KW; NEAL B; PERKOVIC V; HANSEN MK, 2020, '139-LB: The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS', Vol. 69, http://dx.doi.org/10.2337/db20-139-lb

Zhou Z; Jardine M; Heerspink H; Neuen B; Li Q; Arnott C; Mahaffey K; Perkovic V; Neal B, 2020, 'EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION', Chicago, IL, Vol. 75, pp. 221 - 221, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), Chicago, IL, 28 March 2020 - 30 March 2020, http://dx.doi.org/10.1016/S0735-1097(20)30848-2

Conference Presentations

PRATLEY RE; BAERES FMM; BAKRIS G; LAWSON J; MAHAFFEY KW; MANN JF; MERSEBACH H; ROSSING P; TUTTLE KR; PERKOVIC V, 2022, '747-P: Baseline Characteristics of Subjects in the Once-Weekly (OW) Semaglutide FLOW Kidney Outcomes Trial', http://dx.doi.org/10.2337/db22-747-p

OSHIMA M; JARDINE MJ; AGARWAL R; BAKRIS G; CANNON C; CHARYTAN DM; ZEEUW DD; EDWARDS R; GREENE T; LEVIN A; MAHAFFEY KW; NEAL B; POLLOCK CA; ROSENTHAL N; WHEELER DC; ZHANG H; ZINMAN B; PERKOVIC V; HEERSPINK HL, 2020, '26-OR: Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE', http://dx.doi.org/10.2337/db20-26-or

Conference Abstracts

SCIRICA B; BUSE JB; CATARIG AM; JEPPESEN OK; LINCOFF AM; MCGUIRE D; PERKOVIC V; PRATLEY R; STENSEN S; TRAN MC; RYAN D, 2026, '1696-P: Effect of Semaglutide on COVID-19–Related Complications and All-Cause Death: Pooled Analyses of the SELECT, FLOW, and SOUL Trials', in Diabetes, American Diabetes Association, Vol. 75, http://dx.doi.org/10.2337/db26-1696-p

Rizk D; Perkovic V; Kashihara N; Maes B; Rovin B; Trimarchi H; Zhang H; Desai M; Monaco L; Magirr A; Govan L; Hach T; Barratt J, 2026, 'THE APPLAUSE-IGAN TRIAL OF IPTACOPAN: FINAL 24-MONTH RESULTS', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, LA, New Orleans, Vol. 87, pp. S7 - S8, presented at National-Kidney-Foundation Spring Clinical Meetings (SCM), LA, New Orleans, 06 May 2026 - 10 May 2026

Barratt J; Huang M; Hafkin J; Lohrmann E; Xia J; George V; Perkovic V, 2026, 'HYPOGAMMAGOBULINEMIA AND INFECTION RISK IN AN INTERIM ANALYSIS OF THE PHASE 3 VISIONARY TRIAL OF SIBEPRENLIMAB IN IGA NEPHROPATHY', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, Vol. 87, pp. S153 - S153

Rizk D; Jhaveri KD; Workeneh B; Zhang Z; Hafkin J; Shah L; Fajardo C; Lafayette R; Perkovic V, 2026, 'IMPACT OF SGLT2I USE ON SIBEPRENLIMAB OUTCOMES IN IGA NEPHROPATHY (GAN SUBGROUP ANALYSIS FROM THE PHASE 3 VISIONARY TRIAL INTERIM ANALYSIS', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, Vol. 87, pp. Ss167 - S167

Rizk D; Cheung CK; Kooienga L; Jhaveri KD; Zhang Z; Hafkin J; Pinto C; Lafayette R; Perkovic V, 2026, 'SIBEPRENLIMAB IN IGA NEPHROPATHY: ASSESSMENT OF TARGET PROTEINURIA THRESHOLDS IN THE PHASE 3 VISIONARY TRIAL INTERIM ANALYSIS', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, Vol. 87, pp. S166 - S166

Zan J; Wong MG; Kim D; Shi S; Monaghan H; Perkovic V; Lv J; Zhang H, 2025, '#2009 Impact of systemic glucocorticoids on Gd-IgA1 levels in Immunoglobulin A Nephropathy: insights from the TESTING trial', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 40, pp. gfaf116.0437, http://dx.doi.org/10.1093/ndt/gfaf116.0437

Kim D; Woodward M; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Perkovic V; Zhang H; Wong MG, 2025, '#745 Sex differences across treatment response to corticosteroids and kidney outcomes in IgA nephropathy: insights from the TESTING trial', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 40, pp. gfaf116.0351, http://dx.doi.org/10.1093/ndt/gfaf116.0351

Barratt J; Rizk D; Zhang H; Maes B; Kashihara N; Rovin B; Trimarchi H; Kollins D; Desai M; Papachristofi O; Koukouli E; Perkovic V, 2025, 'Effect of iptacopan discontinuation on proteinuria and complement biomarkers in patients with immunoglobulin A nephropathy (IgAN): a post hoc analysis from a Phase II trial', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Vol. 40, http://dx.doi.org/10.1093/ndt/gfaf116.030

Perkovic V; Kollins D; Papachristofi O; Hach T; Jacinto-Sanders S; Merkel T; Renfurm R; Rizk DV, 2024, '#456 Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 39, pp. gfae069-0141-456, http://dx.doi.org/10.1093/ndt/gfae069.141

Rizk DV; Kollins D; Papachristofi O; Hach T; Jacinto-Sanders S; Merkel T; Renfurm R; Perkovic V, 2024, 'EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IGAN STUDY', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, SWEDEN, Stockholm, Vol. 83, pp. 699 - 700, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024

Perkovic V; Kollins D; Papachristofi O; Hach T; Jacinto-Sanders S; Merkel T; Renfurm R; Rizk DV, 2024, 'Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, pp. I255 - I256, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024

Rovin B; Barratt J; Murphy E; Geletka R; Komers R; Perkovic V, 2024, 'SPARSENTAN (SPAR) SHOWS CLINICALLY MEANINGFUL TREATMENT EFFECTS VS IRBESARTAN (IRB) IN PATIENTS WITH IGA NEPHROPATHY (IGAN) IN THE PHASE 3 PROTECT TRIAL', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, CA, Long Beach, Vol. 83, pp. S114 - S114, presented at Spring Clinical Meeting of the National Kidney Foundation, CA, Long Beach, 14 May 2024 - 18 May 2024

Ha J; Fletcher R; Yu J; Arnott C; Jun M; Perkovic V; Badve S; Neuen B, 2024, 'ALBUMINURIA, KIDNEY FUNCTION AND HEART FAILURE IN TYPE 2 DIABETES: A SECONDARY ANALYSIS FROM THE CANVAS PROGRAM AND CREDENCE TRIAL', in NEPHROLOGY, WILEY, Vol. 29, pp. 75 - 75

Neuen B; Fletcher R; Arnott C; Vadagunathan M; Perkovic V; Jardine M; Neal B; Mahaffey K; Heerspink H; Pollock C, 2022, 'CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 15 - 15, http://dx.doi.org/10.26190/unsworks/28407

Tye S; Jong N; Coca SG; Sundstrom J; Arnott C; Neal B; Perkovic V; Vart P; Heerspink HJL, 2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney outcome guided by HbA_1c and predicted risk of kidney failure', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S278 - S278, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022

Schechter M; Koshino A; Jongs N; Neal B; Arnott C; Perkovic V; Hansen MK; Heerspink HJL, 2022, 'Novel subgroups of patients with type 2 diabetes show differential cardiovascular and kidney benefits with canagliflozin: a data-driven proteomic cluster analysis', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S132 - S132, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000841795900252&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

KOSHINO A; SCHECHTER M; SEN T; NEUEN B; ARNOTT C; PERKOVIC V; HANSEN MK; HEERSPINK HL, 2022, '862-P: Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial', in Diabetes, American Diabetes Association, Vol. 71, http://dx.doi.org/10.2337/db22-862-p

Perkovic V; Baeres F; Bakris G; Bosch-Traberg H; Idorn T; Mahaffey K; Mann J; Mersebach H; Rossing P; Tuttle K; Pratley R, 2022, 'FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 37, pp. gfac126.002, http://dx.doi.org/10.1093/ndt/gfac126.002

Kim D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Billot L; Zhang H; Perkovic V; Wong MG, 2022, 'EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISONE IN IGA NEPHROPATHY: THE TESTING TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 14 - 14

Feng Y; Li Q; Finfer S; Myburgh J; Bellomo R; Perkovic V; Jardine M; Wang AY; Gallagher M; Hong D, 2022, 'POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION', in Kidney International Reports, Elsevier BV, Vol. 7, pp. S8 - S8, http://dx.doi.org/10.1016/j.ekir.2022.01.027

Wheeler DC; Weir MR; Gogate J; Perkovic V; Mahaffey KW, 2021, 'Effects of canagliflozin on major adverse cardiovascular events by baseline albuminuria: integrated analyses from the CANVAS Program and CREDENCE trial', in DIABETOLOGIA, SPRINGER, Vol. 64, pp. 227 - 227, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000696550100443&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Arnott C; Li JW; Cannon CP; de Zeeuw D; Neuen BL; Heerspink HJL; Charytan DM; Agarwal A; Huffman MD; Figtree GA; Bakris G; Chang TIH; Feng K; Rosenthal N; Zinman B; Jardine MJ; Perkovic V; Neal B; Mahaffey KW, 2021, 'The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial', in Diabetes Obesity and Metabolism, Vol. 23, pp. 1652 - 1659, http://dx.doi.org/10.1111/dom.14386

Perkovic V; Rovin B; Zhang H; Kashihara N; Maes B; Rizk D; Wang W; Meier M; Kollins D; Papachristofi O; Charney A; Barratt J, 2021, 'A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LNP023 IN PRIMARY IGA NEPHROPATHY PATIENTS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 36, pp. 160 - 160, presented at 58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA), ELECTR NETWORK, 05 June 2021 - 08 June 2021

Feng KY; Gogate J; Damaraju CV; Li J; Jardine MJ; Perkovic V; Blais JD; Pfeifer M; Neal B; Mahaffey KW, 2021, 'Canagliflozin Reduces All-cause Hospitalization in Patients with Type 2 Diabetes Mellitus', in Metabolism, Elsevier, Vol. 116, pp. 154509, http://dx.doi.org/10.1016/j.metabol.2020.154509

Mahaffey KW; Bakris G; Blais J; Cannon CP; Cherney D; Damaraju CV; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Kosiborod M; Levin A; Lingvay I; Weir M; Perkovic V, 2020, 'Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE', in European Heart Journal, Oxford University Press (OUP), Vol. 41, pp. ehaa946.3316, http://dx.doi.org/10.1093/ehjci/ehaa946.3316

Kotwal S; Mehta Y; Lee V; Mallawarchchi A; Ritchie A; Wong M; Makris A; Badve S; Yong K; Jardine M; Perkovic V; Bose B, 2020, 'GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)', in NEPHROLOGY, WILEY, Vol. 25, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mahaffey KW; Li J; Chang TI; Sarraju A; Agarwal R; Charytan DM; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Yavin Y; Jardine M; Perkovic V; Cannon CP, 2020, 'Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial', in European Heart Journal, Oxford University Press (OUP), Vol. 41, pp. ehaa946.1175, http://dx.doi.org/10.1093/ehjci/ehaa946.1175

Back to profile page